event tracking

Department of Neurodegenerative Science

58 results.

May 3, 2024 How understanding proteins can inform new Parkinson’s treatments

Parkinson’s disease is linked to clumps of misshapen proteins that damage brain cells and lead to the disease’s hallmark symptoms.

Dr. Michael Henderson, an…

May 1, 2024 Western Michigan University Homer Stryker M.D. School of Medicine, Van Andel Institute and Western Michigan University Join the National Network of Depression Centers

ANN ARBOR, Mich. (May 1, 2024) — Western Michigan University Homer Stryker M.D. School of Medicine (WMed), Van Andel Institute (VAI) and Western Michigan University…

April 16, 2024 Scientists identify cell vulnerability ‘fingerprint’ related to Parkinson’s, Lewy body dementia

GRAND RAPIDS, Mich. (April 16, 2024) — A new study from Van Andel Institute scientists offers a first look into the complex molecular changes that occur…

April 11, 2024 Van Andel Institute to recognize eminent Parkinson’s disease scientist Dr. Anders Björklund with 2024 Jay Van Andel Award

GRAND RAPIDS, Mich. (April 11, 2024) — Van Andel Institute has named pioneering scientist Anders Björklund, M.D., Ph.D., as recipient of its 2024

April 3, 2024 Phase 2 clinical trial of Type 2 diabetes drug for treatment of Parkinson’s shows positive and promising results

LONDON (April 3, 2024) — Results from a one-year, phase 2 clinical trial of the Type 2 diabetes drug lixisenatide suggest that the treatment may…

March 6, 2024 Van Andel Institute announces 2024 Public Lecture Series

GRAND RAPIDS, Mich. (March 6, 2024) — Van Andel Institute’s free Public Lecture Series returns March 20. This year’s lineup tackles topics such as cancer and nutrition,…

February 23, 2024 Cure Parkinson's and Van Andel Institute fund Phase 2 clinical trial of dapansutrile for Parkinson’s

LONDON (Feb. 23, 2024) — Cure Parkinson’s and Van Andel Institute are delighted to announce funding for a Phase 2 clinical trial…